[Potentially inappropriate prescribing in older Spanish population according to STOPP/START criteria (STARTREC study)].
OBJECTIVE
Rational prescribing in older people is a priority for health care organizations. The STOPP/START screening tool has been developed to identify potentially inappropriate prescribing (PIP) in individuals. In a primary care setting, STOPP/START can estimate PIP prevalence and related factors at population level. The aim of this study is to measure the prevalence rates of PPI in elderly population using clinical and prescription claim databases.


METHODS
Cross-sectional population study.


METHODS
Primary Care, Lleida Health Region, Spain.


METHODS
45.408 patients 70 years old and over, attended in the primary health care centers at least once the last year.


METHODS
43 STOPP and 12 START criteria are applied to their 2012 clinical and prescription records. Logistic regression models are adjusted to determine PIP association with several factors.


RESULTS
45,408 patients are included. The mean age is 79.7 years, 58% being female. The overall prevalence of PPI is 58.1%. According to STOPP, the most common drugs identified are benzodiazepines, non-steroidal anti-inflammatory drugs and proton pump inhibitors; according to START, osteoporosis treatments, antiplatelet agents, statins, metformin and beta blockers. PIP increases with age and polypharmacy and it is higher in long-term care facilities residents and patients receiving home health care.


CONCLUSIONS
In our Health Region, at least 50% of the population aged 70 or older has one or more PIP, according to STOPP/START criteria.
Centro de Atención Primaria Primer de Maig, Institut Català de la Salut, Lleida, España; Unitat de Suport a la Recerca Lleida-Pirineus, Institut d'Investigació en Atenció Primària J Gol (IDIAP J Gol), Lleida, España. Electronic address: icruz.lleida.ics@gencat.cat.
Inés
I
Cruz-Esteve
Unitat de Suport a la Recerca Lleida-Pirineus, Institut d'Investigació en Atenció Primària J Gol (IDIAP J Gol), Lleida, España.
Josep Ramón
JR
Marsal-Mora
Centro de Atención Primaria Primer de Maig, Institut Català de la Salut, Lleida, España; Unitat de Suport a la Recerca Lleida-Pirineus, Institut d'Investigació en Atenció Primària J Gol (IDIAP J Gol), Lleida, España.
Gisela
G
Galindo-Ortego
Unidad de Farmacia, Región Sanitaria de Lleida, Servei Català de la Salut, Lleida, España.
Leonardo
L
Galván-Santiago
Servicio de Geriatría, Hospital Santa María, Gestión de Servicios Sanitarios, Lleida, España.
Marcos
M
Serrano-Godoy
Unidad de Farmacia, Institut Català de la Salut, Lleida, España.
Esther
E
Ribes-Murillo
Unitat de Suport a la Recerca Lleida-Pirineus, Institut d'Investigació en Atenció Primària J Gol (IDIAP J Gol), Lleida, España.
Jordi
J
Real-Gatius
D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D000067561:Potentially Inappropriate Medication List / Q000592:standards* / Q000706:statistics & numerical data*; D013030:Spain
Aged; Ancianos; Atención primaria; Community health planning; Inappropriate prescribing; Polifarmacia; Polypharmacy; Prescripción inapropiada; Primary health care; Salud comunitaria
Rev Esp Geriatr Gerontol. 2011 May-Jun;46(3):125-30
21497956
Aten Primaria. 2015 Jan;47(1):38-47
25113921
Eur J Clin Pharmacol. 2012 Oct;68(10):1425-33
22447297
Rev Esp Geriatr Gerontol. 2011 May-Jun;46(3):117-8
21524819
Int J Clin Pharm. 2013 Apr;35(2):230-5
23225094
Age Ageing. 2015 Mar;44(2):213-8
25324330
Semergen. 2013 Nov-Dec;39(8):413-20
24230489
Rev Esp Geriatr Gerontol. 2013 Nov-Dec;48(6):265-8
24094675
Clin Pharmacol Ther. 2011 Jun;89(6):845-54
21508941
Arch Intern Med. 2011 Jun 13;171(11):1013-9
21670370
BMC Fam Pract. 2014 Apr 02;15:59
24690127
Drugs Aging. 2013 Jan;30(1):39-49
23229766
Br J Clin Pharmacol. 2010 May;69(5):543-52
20573091
Age Ageing. 2014 Nov;43(6):773-8
24963101
BMC Geriatr. 2009 Jan 28;9:5
19175914
Br J Clin Pharmacol. 2009 Dec;68(6):936-47
20002089
PLoS One. 2013 May 17;8(5):e62401
23690938
Eur J Gen Pract. 2014 Dec;20(4):281-9
24702040
Rev Esp Geriatr Gerontol. 2009 Sep-Oct;44(5):273-9
19540624
J Am Geriatr Soc. 2014 Sep;62(9):1658-65
25243680
Rev Esp Salud Publica. 2012 Jul-Aug;86(4):419-34
23076087
Aten Primaria. 2006 Nov 30;38(9):476-80
17194349
Int J Clin Pharmacol Ther. 2008 Feb;46(2):72-83
18218287
Rev Esp Geriatr Gerontol. 2011 May-Jun;46(3):170-1; author reply 170
21497952
Drugs Aging. 2012 Oct;29(10):829-37
23044639
Age Ageing. 2009 Sep;38(5):603-6
19435757